Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when RBB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRBB Bancorp board member Dr. Christopher Lin to retire at 2026 annual meeting
Filed April 6, 2026 · Period ending April 1, 2026 · ~1 min read
Key Changes
-
low
Dr. Christopher Lin notified the board on April 1, 2026 that he will retire from RBB Bancorp's board and Royal Business Bank's board effective at the 2026 Annual Meeting and will not seek re-election.
Item 5.02 verify on EDGAR → -
low
Dr. Lin currently serves on three board committees (Audit, Directors Loan, and Community Reinvestment Act) and will step down from all committee roles upon retirement.
Item 5.02 verify on EDGAR → -
low
The company explicitly stated Dr. Lin's retirement involves no disagreement with management or the board on operations, policies, or practices.
Item 5.02 verify on EDGAR →
Summary
RBB Bancorp disclosed a routine board transition as Dr. Christopher Lin announced his retirement from both the company's board and its subsidiary Royal Business Bank's board, effective at the upcoming 2026 Annual Meeting of Shareholders. Dr. Lin, who serves on three board committees including the Audit Committee, will not stand for re-election.
For retail investors, this is a standard governance matter with minimal immediate impact. The company included customary language confirming the departure involves no disagreement with management, which is typical for planned retirements.
Board composition changes are normal in the course of business, though the departure from the Audit Committee means the company will need to fill that role with a qualified independent director. Investors should watch for the company's proxy statement ahead of the annual meeting, which will detail the board's composition going forward and any new director nominees to fill Dr. Lin's seat and committee positions.
Section-by-Section Diff
Event · Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
Dr. Lin’s decision to retire did not involve any disagreement with Company management, the Board or the Bank Board on any matter relating to the Company’s operations, policies or practices.
The Company explicitly disclosed that Dr. Lin's retirement decision was not related to any disagreement with management or the Board regarding operations, policies, or practices. This is standard disclosure language for director departures.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify